Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, Illeperuma A, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Weiland O, Reesink HW, Ferenci P, Hézode C, Esteban R; VALENCE Investigators.

N Engl J Med. 2014 May 22;370(21):1993-2001. doi: 10.1056/NEJMoa1316145. Epub 2014 May 4.

PMID:
24795201
[PubMed - indexed for MEDLINE]
2.

SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients.

Dieterich D, Asselah T, Guyader D, Berg T, Schuchmann M, Mauss S, Ratziu V, Ferenci P, Larrey D, Maieron A, Stern JO, Ozan M, Datsenko Y, Böcher WO, Steinmann G.

Antimicrob Agents Chemother. 2014 Jun;58(6):3429-3436. Epub 2014 Apr 7.

PMID:
24709256
[PubMed - as supplied by publisher]
Free Article
3.

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Hézode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Chazouilleres O, Abergel A, Guyader D, Metivier S, Tran A, Di Martino V, Causse X, Dao T, Lucidarme D, Portal I, Cacoub P, Gournay J, Grando-Lemaire V, Hillon P, Attali P, Fontanges T, Rosa I, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group.

Gastroenterology. 2014 Jul;147(1):132-142.e4. doi: 10.1053/j.gastro.2014.03.051. Epub 2014 Apr 3.

PMID:
24704719
[PubMed - in process]
4.

Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome.

Bardou-Jacquet E, Lainé F, Morcet J, Perrin M, Guyader D, Deugnier Y.

Eur J Gastroenterol Hepatol. 2014 Apr;26(4):418-21. doi: 10.1097/MEG.0000000000000058.

PMID:
24557330
[PubMed - in process]
5.

Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.

Amiot L, Vu N, Rauch M, L'Helgoualc'h A, Chalmel F, Gascan H, Turlin B, Guyader D, Samson M.

J Hepatol. 2014 Feb;60(2):245-52. doi: 10.1016/j.jhep.2013.09.006. Epub 2013 Sep 12.

PMID:
24036009
[PubMed - in process]
6.

AST/ALT ratio is not an index of liver fibrosis in chronic hepatitis C when aminotransferase activities are determinate according to the international recommendations.

Guéchot J, Boisson RC, Zarski JP, Sturm N, Calès P, Lasnier E; ANRS HCEP 23 Fibrostar Group.

Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):467-72. doi: 10.1016/j.clinre.2013.07.003. Epub 2013 Aug 8.

PMID:
23932706
[PubMed - indexed for MEDLINE]
7.

The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial.

Chapplain JM, Bellissant E, Guyader D, Molina JM, Poizot-Martin I, Perré P, Pialoux G, Turlin B, Mouchel C, Renault A, Michelet C; ANRS HC-12 Study Group.

J Infect. 2013 Oct;67(4):313-21. doi: 10.1016/j.jinf.2013.05.007. Epub 2013 Jun 22.

PMID:
23800784
[PubMed - indexed for MEDLINE]
8.

Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis.

Bardou-Jacquet E, Philip J, Lorho R, Ropert M, Latournerie M, Houssel-Debry P, Guyader D, Loréal O, Boudjema K, Brissot P.

Hepatology. 2014 Mar;59(3):839-47. doi: 10.1002/hep.26570. Epub 2014 Jan 27.

PMID:
23775519
[PubMed - indexed for MEDLINE]
9.

Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).

Rosenthal E, Piroth L, Cua E, Joulié A, Ravaux I, Chauveau M, Lacombe K, Cotte L, Bonnard P, Weiss L, Longuet M, Pradier C, Cacoub P; GERMIVIC Study Group.

AIDS Care. 2014 Feb;26(2):176-85. doi: 10.1080/09540121.2013.803014. Epub 2013 Jun 11.

PMID:
23756091
[PubMed - in process]
10.

Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.

Boursier J, de Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, Bertrais S, Rousselet MC, Calès P; Multicentre group ANRS HC EP23 FIBROSTAR.

J Gastroenterol. 2014 Mar;49(3):527-37. doi: 10.1007/s00535-013-0819-9. Epub 2013 May 17.

PMID:
23681425
[PubMed - in process]
11.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

Hézode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourlière M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Métivier S, Tran A, Serfaty L, Abergel A, Causse X, Di Martino V, Guyader D, Lucidarme D, Grando-Lemaire V, Hillon P, Feray C, Dao T, Cacoub P, Rosa I, Attali P, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP; CUPIC Study Group.

J Hepatol. 2013 Sep;59(3):434-41. doi: 10.1016/j.jhep.2013.04.035. Epub 2013 May 10.

PMID:
23669289
[PubMed - indexed for MEDLINE]
12.

Effect of alcohol consumption on liver stiffness measured by transient elastography.

Bardou-Jacquet E, Legros L, Soro D, Latournerie M, Guillygomarc'h A, Le Lan C, Brissot P, Guyader D, Moirand R.

World J Gastroenterol. 2013 Jan 28;19(4):516-22. doi: 10.3748/wjg.v19.i4.516.

PMID:
23382630
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Large granular lymphocyte leukemia associated with hepatitis C virus infection and B cell lymphoma: improvement after antiviral therapy.

Poullot E, Bouscary D, Guyader D, Ghandour C, Roussel M, Fest T, Houot R, Lamy T.

Leuk Lymphoma. 2013 Aug;54(8):1797-9. doi: 10.3109/10428194.2012.752486. Epub 2012 Dec 26. No abstract available.

PMID:
23176408
[PubMed - indexed for MEDLINE]
14.

S(N)2' reaction of allylic difluorides with lithium amides and thiolates.

Bergeron M, Guyader D, Paquin JF.

Org Lett. 2012 Dec 7;14(23):5888-91. doi: 10.1021/ol302802r. Epub 2012 Nov 12.

PMID:
23145465
[PubMed - indexed for MEDLINE]
15.

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.

Sulkowski MS, Poordad F, Manns MP, Bronowicki JP, Rajender Reddy K, Harrison SA, Afdhal NH, Sings HL, Pedicone LD, Koury KJ, Sniukiene V, Burroughs MH, Albrecht JK, Brass CA, Jacobson IM; SPRINT-2 Trial Investigators.

Hepatology. 2013 Mar;57(3):974-84. doi: 10.1002/hep.26096. Epub 2013 Feb 11.

PMID:
23081753
[PubMed - indexed for MEDLINE]
16.

Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy.

Bosselut N, Taibi L, Guéchot J, Zarski JP, Sturm N, Gelineau MC, Poggi B, Thoret S, Lasnier E, Baudin B, Housset C, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group.

Clin Chim Acta. 2013 Jan 16;415:63-8. doi: 10.1016/j.cca.2012.09.020. Epub 2012 Sep 27.

PMID:
23022619
[PubMed - indexed for MEDLINE]
17.

Determination of reliability criteria for liver stiffness evaluation by transient elastography.

Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, Gallois Y, Oberti F, Bertrais S, Calès P; Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies.

Hepatology. 2013 Mar;57(3):1182-91. doi: 10.1002/hep.25993. Epub 2013 Feb 4.

PMID:
22899556
[PubMed - indexed for MEDLINE]
18.

Factors that predict response of patients with hepatitis C virus infection to boceprevir.

Poordad F, Bronowicki JP, Gordon SC, Zeuzem S, Jacobson IM, Sulkowski MS, Poynard T, Morgan TR, Molony C, Pedicone LD, Sings HL, Burroughs MH, Sniukiene V, Boparai N, Goteti VS, Brass CA, Albrecht JK, Bacon BR; SPRINT-2 and RESPOND-2 Investigators.

Gastroenterology. 2012 Sep;143(3):608-18.e1-5. doi: 10.1053/j.gastro.2012.05.011. Epub 2012 May 21.

PMID:
22626609
[PubMed - indexed for MEDLINE]
19.

Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin.

Larrey D, Carenco C, Guyader D, Boyer N, Benhamou Y, Pageaux GP, Rouzier R, Marcellin P.

Antivir Ther. 2012;17(5):927-32. doi: 10.3851/IMP2126. Epub 2012 May 18.

PMID:
22611092
[PubMed - indexed for MEDLINE]
20.

Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.

Guéchot J, Trocmé C, Renversez JC, Sturm N, Zarski JP; ANRS HC EP 23 Fibrostar Study Group.

Clin Chem Lab Med. 2012 Jan 13;50(4):693-9. doi: 10.1515/cclm-2011-0858.

PMID:
22505560
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk